Endoscopy & Procedures · Article 179
When Should Endoscopic Full-Thickness Resection Be Used?
Full-thickness resection requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Full-thickness resection: practical clinical approach
This page focuses on Full-thickness resection with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.
External guidance for Full-thickness resection
Clinical takeaway: For Full-thickness resection, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.
EFTR solves the nonlifting problem
A scarred lesion can be captured and resected through all bowel-wall layers after secure closure.
Size limits are real
Clip-based EFTR devices work best for relatively small lesions that can be drawn fully into the cap.
It is not a substitute for oncologic surgery
Deep invasive cancer with nodal risk still requires lymph-node assessment.
Practical clinical algorithm
1. Confirm that conventional EMR/ESD is unsuitable.
2. Assess lesion size, fibrosis and location.
3. Exclude deep invasive cancer requiring oncologic surgery.
4. Use EFTR in an experienced center with complication-management capability.
5. Plan histologic and site surveillance.
Common mistakes to avoid
- Attempting EFTR on lesions too large for reliable capture.
- Using EFTR to avoid surgery for cancer with nodal risk.
- Ignoring appendicitis risk near the appendiceal orifice.
- Performing the procedure without advanced closure/rescue expertise.
- Failing to retrieve the specimen intact.
Trainee takeaway
EFTR is a niche organ-preserving tool for small difficult lesions—especially scarred or nonlifting lesions—not a universal alternative to EMR, ESD or surgery.
Frequently asked questions
What is a classic colorectal indication?
A small nonlifting recurrent adenoma in a scarred resection site.
Can EFTR remove subepithelial lesions?
Yes, in selected anatomically suitable cases.
Does EFTR treat lymph nodes?
No, so it is not adequate oncologic therapy for cancers with meaningful nodal risk.
Suggested free reading
Continue with these free books by Dr. Alan B. R. Thomson:
References
1. Thomson ABR. Endoscopy and Diagnostic Imaging. Part I. CAPstone Academic Publishers; 2012.
2. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.
3. D’Souza LS, et al. AGA Clinical Practice Update on Endoscopic Full-Thickness Resection for Gastrointestinal Subepithelial Lesions. Gastroenterology. 2024.
Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.
Free GI & Hepatology Updates
Continue Learning With Dr Alan B. R. Thomson
Receive evidence-based clinical teaching, updated reviews, practical reference material and new free GI and hepatology resources.
Free to subscribe. Educational resources on GIandHepatology.com remain freely available without registration.